Abstract
Mitochondrial dysfunction is a major mechanism whereby drugs can induce liver injury and other serious side effects, such as lactic acidosis and rhabdomyolysis, in some patients. Several in vitro and in vivo investigations can be performed in order to determine if drugs can disturb mitochondrial fatty acid oxidation (FAO) and the oxidative phosphorylation (OXPHOS) process, deplete hepatic mitochondrial DNA (mtDNA), or trigger the opening of the mitochondrial permeability transition pore (MPT). Among these investigations, mitochondrial respiration is a relatively easy test to measure the potential toxicity of a drug. The use of cells instead of isolated mitochondria allows one to test the toxic effect of a parent compound and its metabolites. The use of rat hepatocytes can detect drugs involved in drug-induced liver injuries (DILI). The method consists in measuring oxygen consumption by using a Clark electrode in a chamber containing a suspension of hepatocytes pre-incubated with drug.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Lee, W.M. (2003) Drug-induced hepatotoxicity. N. Engl. J. Med. 349, 474–485.
Pessayre, D., Fromenty, B., Mansouri, A., and Berson, A. Hepatotoxicity Due to Mitochondrial Injury, in: Kaplowitz N. & DeLeve L.D. (Eds), Drug-Induced Liver Disease (second edition), Informa Healthcare, New York. 2007, pp.49–84.
Fromenty, B. and Pessayre, D. (1995) Inhibition of mitochondrial beta-oxidation as a mechanism of hepatotoxicity. Pharmacol. Ther. 67, 101–154.
Pessayre, D., Mansouri, A., Haouzi, D., and Fromenty, B. (1999) Hepatotoxicity due to mitochondrial dysfunction. Cell Biol. Toxicol. 15, 367–373.
Igoudjil, A., Begriche, K., Pessayre, D., and Fromenty, B. (2006) Mitochondrial, metabolic and genotoxic effects of antiretroviral nucleoside reverse-transcriptase inhibitors. Curr. Med. Chem. Anti-Infective Agents 5, 273–292.
Dykens, J.A. and Will, Y. (2007) The significance of mitochondrial toxicity testing in drug development. Drug Discov. Today 12, 777–785.
Scatena, R., Bottoni, P., Botta, G., Martorana, G.E., and Giardina, B. (2007) The role of mitochondria in pharmacotoxicology: a reevaluation of an old, newly emerging topic. Am. J. Physiol. Cell Physiol. 293, C12–C21.
Salway, J.G. Metabolism at a Glance (first edition), Blackwell Scientific, London. 1994.
Pessayre, D. and Fromenty, B. (2005) NASH: a mitochondrial disease. J. Hepatol. 42, 928–940.
Navarro, A. and Boveris A. (2007) The mitochondrial energy transduction system and the aging process. Am. J. Physiol. Cell Physiol. 292, C670–C686.
Berson, A., Renault, S., Letteron, P., Robin, M.A., Fromenty, B., Fau, D., Le Bot, M.A., Riche, C., Durand-Schneider, A.M., Feldmann, G., and Pessayre, D. (1996) Uncoupling of rat and human mitochondria: A possible explanation for tacrine-induced liver dysfunction. Gastroenterol. 110, 1878–1890.
Mosman, T. (1983) Rapid colorimetric assay for celullar growth and survival: application to proliferation and cytotoxicity assays. J. Immunol. Methods 65, 55–63.
Borenfreund, E. and Puerner, J.A. (1985) Toxicity determined in vitro by morphological alterations and Neutral Red absorption. Toxicology Lett. 24, 119–124.
Acknowledgments
The authors would like to thank Delphine Hoët for her expertise and her support in hepatocyte culture.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2011 Springer Science+Business Media, LLC
About this protocol
Cite this protocol
Marchandeau, JP., Labbe, G. (2011). Evaluation of Mitochondrial Respiration in Cultured Rat Hepatocytes. In: Gautier, JC. (eds) Drug Safety Evaluation. Methods in Molecular Biology, vol 691. Humana Press. https://doi.org/10.1007/978-1-60761-849-2_14
Download citation
DOI: https://doi.org/10.1007/978-1-60761-849-2_14
Published:
Publisher Name: Humana Press
Print ISBN: 978-1-60327-186-8
Online ISBN: 978-1-60761-849-2
eBook Packages: Springer Protocols